Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and iloprost

gemcitabine has been researched along with iloprost in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Genet, D; Labourey, JL; Ly, K; Martin, J; Szelag, JC; Tubiana-Mathieu, N; Vénat-Bouvet, L1
Bätge, R; Egberts, EH; Holstein, A1

Other Studies

3 other study(ies) available for gemcitabine and iloprost

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine.
    Anti-cancer drugs, 2003, Volume: 14, Issue:10

    Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Fingers; Gangrene; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Iloprost; Male; Middle Aged; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Vasodilator Agents

2003
Gemcitabine induced digital ischaemia and necrosis.
    European journal of cancer care, 2010, Volume: 19, Issue:3

    Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Fatal Outcome; Female; Fingers; Gemcitabine; Humans; Iloprost; Ischemia; Magnetic Resonance Angiography; Necrosis; Urinary Bladder Neoplasms; Vasodilator Agents

2010